BBR Partners »

Ovid Therapeutics shares owned by BBR Partners

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by BBR Partners from 13F filings

Historical chart of BBR Partners investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by BBR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by BBR Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $15k 13k 1.18
2024-06-30 $9.6k 13k 0.77

More positions owned by BBR Partners

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
United Parcel Service CL B (UPS)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Kkr & Co Cl A (KKR)
Vanguard Index Fds Total Stk Mkt (VTI)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard World Fds Inf Tech Etf (VGT)
Philip Morris International (PM)
Alphabet Cap Stk Cl A (GOOGL)
Abbvie (ABBV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Exxon Mobil Corporation (XOM)

View all positions for BBR Partners

Top funds holding Ovid Therapeutics

Rubric Capital Management
BlackRock
BlackRock
BVF
Vanguard Group
Siren
Acadian Asset Management
Kennedy Capital Management
Jpmorgan Chase & Co
Driehaus Capital Management
State Street Corporation
Geode Capital Management
TLS Advisors
Wells Fargo & Company
Northern Trust

View all funds holding Ovid Therapeutics